Stocks

Citigroup Released Q2 2022 Financial Report and Key Metrics on Friday

 Stocks

The Bank manages assets (AUM) with a total value of more than $2 trillion

July 18, 2022

views 1637
JP Morgan Chase Disappointed by Muted Numbers, Share Buyback Suspension and Bleak Guidance

JP Morgan Chase Disappointed by Muted Numbers, Share Buyback Suspension and Bleak Guidance

Shares of JP Morgan Chase (JPM) were down 3.5% on the reporting day, July 14, after a muted quarterly report. JPM's Q2 earnings per share of $2.76 fell short of the consensus estimate of $2.91; versus $2.63 in the first quarter of 2022 and $3.78 in the last year quarter.

July 15, 2022

views 1685
JPMorgan Shares Dropped as Banking Giant Posted Underwhelming Growth in Q3

JPMorgan Shares Dropped as Banking Giant Posted Underwhelming Growth in Q3

JPMorgan Chase (JPM) yesterday posted a neutral-to-good quarter and outlook propelled by some optimism for the economy and the financials sector as a whole. These results included a $2.1 billion net credit reserve release.

October 14, 2021

views 1843

Popular posts

Stocks

Apple February MoM iPhone Sales down 9% in U.S., 16% in China.

April 1, 2024

views 2976
Cryptocurrencies

Elon Musk's Tesla has Added a Dogcoin (DOGE) Payment Form to its Website. The Meme Coin Soars.

May 6, 2024

views 2968
Stocks

JPMorgan's Q1 Revenue Up by 9% to $41.93 Billion, but Guidance Disappointed

April 12, 2024

views 2888
Commodities

Global Grain Price Recoveries Appears Excessively Bullish vis-à-vis Inventories and Weather Factors

April 24, 2024

views 2874
Currencies

USD May Return to Strengthening on Disappointing Inflation Report

April 10, 2024

views 2819
show more

Tech summary box

top crypto

© 2024 DRT

Client Agreement AML Policy Refund and Withdrawal policy Privacy Policy

Trading financial instruments involves substantial risk and is not suitable for all investors. The information herein is not a recommendation to trade nor investment research or an offer to buy or sell any instrument. It does not take into account your particular investment objectives, financial situation or needs and does not create a binding obligation on any of the Dr Trade Company to enter into any transaction with you. You are advised to perform an independent investigation of any transaction to determine whether any transaction is suitable for you.